Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Liraglutide was approved by the FDA for marketing in the United States in 2010 and officially launched in China in 2011
Use only in controlled laboratory settings by qualified personnel following appropriate safety procedures.
Peptide dosing is a delicate and complicated art
Molecular Formula: C228H388N86O64 Molecular Weight: 5358 g/mol Sequence: H-D-Leu-D-Thr-D-Leu-D-Arg-D-Lys-D-Glu-D-Pro-D-Ala-D-Ser-D-Glu-D-Ile-D-Ala-D-Gln-D-Ser-D-Ile-D-Leu-D-Glu-D-Ala-D-Tyr-D-Ser-D-Gln-D-Asn-Gly-D-Trp-D-Ala-D-Asn-D-Arg-D-Arg-D-Ser-Gly-Gly-Lys-Arg-Pro-DL-Pro-DL-Pro-Arg-Arg-Arg-Gln-Arg-Arg-Lys-Lys-Arg-Gly-OH View our FOXO4-DRI High-Performance Liquid Chromatography (HPLC) Certificate here
Long term effects of Liraglutide in Japanese patients with type 2 diabetes among the subgroups with different renal functions: Results of 2-year prospective study
